ArticleFrontiers in molecular biosciences2022

Using CRISPR/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel

Robin A Pilz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.